Bahar Rastegar

ORCID: 0009-0000-8127-9055
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal and related cancers
  • Cancer Genomics and Diagnostics
  • Reproductive Biology and Fertility
  • Radiomics and Machine Learning in Medical Imaging
  • Advanced X-ray Imaging Techniques
  • Cancer Cells and Metastasis
  • Handwritten Text Recognition Techniques
  • Digestive system and related health
  • Hedgehog Signaling Pathway Studies

Lund University
2023

Skåne University Hospital
2023

Abstract Purpose: While patients with intermediate-risk (IR) Wilms tumors now have an overall survival (OS) rate of almost 90%, those affected by high-stage diffuse anaplasia OS only around 50%. We here identify key events in the pathogenesis mapping cancer cell evolution over anatomic space tumors. Experimental Design: spatially mapped subclonal landscapes a retrospective cohort 20 using high-resolution copy-number profiling and TP53 mutation analysis followed clonal deconvolution...

10.1158/1078-0432.ccr-23-0311 article EN cc-by-nc-nd Clinical Cancer Research 2023-05-04

<p>Supplementary Table 3. Table. Sample list with TP53 status. All 20 WT cases and their corresponding samples are listed. ‘Sample position’ refers to the individual sample its position in a certain paraffin block (see Figure 1 for details.) IR= intermediate risk, BT= blastemal type, DA= diffuse anaplasia. Headings marked grey show sequencing results; wt=wild mut=mutation, NA= not annotated (i.e. sequenced), aa= amino acid, REF= reference nucleotide, ALT= alternative ref= number of...

10.1158/1078-0432.27031429.v1 preprint EN 2024-09-16

<p>Supplementary Table 4. Segmental aberrations. All 20 Wilms tumor (WT) cases and their corresponding samples are listed. ‘Sample position’ refers to the individual sample its position in a certain paraffin block (see Figure 1 for details.) For each genetic event following information is given: ploidy level (Ploidy), chromosome (chr), genomic start end positions, events annotated as gain, loss, CNNI (copy neutral imbalance) or homozygous length of aberration (bp), which chromosomal...

10.1158/1078-0432.27031426.v1 preprint EN 2024-09-16

<p>Supplementary Table 2. Representativeness of study participants. Details on how the patients with Wilms tumor in present compare to general population diagnosed tumor.</p>

10.1158/1078-0432.27031432.v1 preprint EN 2024-09-16

<div>Abstract<p>Purpose: While patients with intermediate-risk Wilms tumors (WT) now have an overall survival rate of almost 90%, those affected by high-stage diffuse anaplasia (DA) only around 50%. We here identify key events in the pathogenesis DA mapping cancer cell evolution over anatomic space WTs. Experimental Design: spatially mapped subclonal landscapes a retrospective cohort 20 WTs using high-resolution copy number profiling and <i>TP53</i> mutation analysis...

10.1158/1078-0432.c.6682878.v3 preprint EN 2024-09-16

<p>Supplementary Table 1. Overview of the study cohort and clinical data. This table contains basic information, including age, sex, whether tumors were uni- or bilateral, histology, stage, risk group, treatment to which resection specimen analyzed was subjected to, final outcome record adverse events.</p>

10.1158/1078-0432.27031435.v1 preprint EN 2024-09-16

<p>Supplementary Table 4. Segmental aberrations. All 20 Wilms tumor (WT) cases and their corresponding samples are listed. ‘Sample position’ refers to the individual sample its position in a certain paraffin block (see Figure 1 for details.) For each genetic event following information is given: ploidy level (Ploidy), chromosome (chr), genomic start end positions, events annotated as gain, loss, CNNI (copy neutral imbalance) or homozygous length of aberration (bp), which chromosomal...

10.1158/1078-0432.27031426 preprint EN 2024-09-16

<p>Supplementary Table 1. Overview of the study cohort and clinical data. This table contains basic information, including age, sex, whether tumors were uni- or bilateral, histology, stage, risk group, treatment to which resection specimen analyzed was subjected to, final outcome record adverse events.</p>

10.1158/1078-0432.27031435 preprint EN 2024-09-16

<p>Supplementary Table 3. Table. Sample list with TP53 status. All 20 WT cases and their corresponding samples are listed. ‘Sample position’ refers to the individual sample its position in a certain paraffin block (see Figure 1 for details.) IR= intermediate risk, BT= blastemal type, DA= diffuse anaplasia. Headings marked grey show sequencing results; wt=wild mut=mutation, NA= not annotated (i.e. sequenced), aa= amino acid, REF= reference nucleotide, ALT= alternative ref= number of...

10.1158/1078-0432.27031429 preprint EN 2024-09-16

<p>Supplementary Table 2. Representativeness of study participants. Details on how the patients with Wilms tumor in present compare to general population diagnosed tumor.</p>

10.1158/1078-0432.27031432 preprint EN 2024-09-16

<p>Supplementary Table 4. Segmental aberrations. All 20 Wilms tumor (WT) cases and their corresponding samples are listed. ‘Sample position’ refers to the individual sample its position in a certain paraffin block (see Figure 1 for details.) For each genetic event following information is given: ploidy level (Ploidy), chromosome (chr), genomic start end positions, events annotated as gain, loss, CNNI (copy neutral imbalance) or homozygous length of aberration (bp), which chromosomal...

10.1158/1078-0432.23301888.v1 preprint EN cc-by 2023-06-06

<p>Supplementary Table 2. Representativeness of study participants. Details on how the patients with Wilms tumor in present compare to general population diagnosed tumor.</p>

10.1158/1078-0432.23301894.v1 preprint EN cc-by 2023-06-06

<p>Supplementary Table 1. Overview of the study cohort and clinical data. This table contains basic information, including age, sex, whether tumors were uni- or bilateral, histology, stage, risk group, treatment to which resection specimen analyzed was subjected to, final outcome record adverse events.</p>

10.1158/1078-0432.23301897 preprint EN cc-by 2023-06-06

<p>Supplementary Table 4. Segmental aberrations. All 20 Wilms tumor (WT) cases and their corresponding samples are listed. ‘Sample position’ refers to the individual sample its position in a certain paraffin block (see Figure 1 for details.) For each genetic event following information is given: ploidy level (Ploidy), chromosome (chr), genomic start end positions, events annotated as gain, loss, CNNI (copy neutral imbalance) or homozygous length of aberration (bp), which chromosomal...

10.1158/1078-0432.23301888 preprint EN cc-by 2023-06-06

<p>Supplementary Table 3. Table. Sample list with TP53 status. All 20 WT cases and their corresponding samples are listed. ‘Sample position’ refers to the individual sample its position in a certain paraffin block (see Figure 1 for details.) IR= intermediate risk, BT= blastemal type, DA= diffuse anaplasia. Headings marked grey show sequencing results; wt=wild mut=mutation, NA= not annotated (i.e. sequenced), aa= amino acid, REF= reference nucleotide, ALT= alternative ref= number of...

10.1158/1078-0432.23301891.v1 preprint EN cc-by 2023-06-06
Coming Soon ...